To be eligible for this study, patients must meet several criteria, including but not limited to the following:
- Patients must have ovarian, fallopian tube, or primary peritoneal cancer that has returned or persists despite prior therapy.
- Patients must have received one prior platinum-containing chemotherapy regimen and may have had up to one additional regimen of chemotherapy for recurrent disease.
- Patients must have recovered from the serious side effects of prior therapies before entering the study. At least 3 weeks must have passed since completion of chemotherapy and 4 weeks since radiation therapy or major surgery.
- This study is open to patients age 18 and older.
For more information about this study and to inquire about eligibility, please contact Dr. Vicky Makker at 646-888-4224.